investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

Eusebio Manchado-Robles

Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers

Trachea, bronchus and lung

Jeffrey Mackeigan

Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer

Trachea, bronchus and lung

Pathology

Martin Mcintosh

Profiling cancer neoantigen repertoires and validating immunotherapy targets

Trachea, bronchus and lung

Elisabeth D Martinez

Characterization of the biological activities of novel epigenetic modulators

Trachea, bronchus and lung

Pathology

Jeffrey Schlom

Strategies for Cancer Vaccine Development: Preclinical Studies

Trachea, bronchus and lung

Pathology

Bruce E. Johnson

EGFR Mutations in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Sandy A. Napel

Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

Dieter Haemmerich

In vivo Derived in Silico Model for DDS Optimization

Trachea, bronchus and lung